Canton Strategic Holdings (CNTN) Cash & Equivalents (2020 - 2026)
Canton Strategic Holdings posted quarterly Cash & Equivalents of $41.5 million for Q1 2026, up 3760.12% year-on-year from $1.1 million in Q1 2025, and up 143.84% on a QoQ basis from $17.0 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Cash & Equivalents data on file, last reported at $41.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 3760.12% year-over-year to $41.5 million; the trailing twelve-month figure through Mar 2026 stood at $41.5 million (up 3760.12% YoY), and the FY2025 full-year result was $17.0 million, up 378.53% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $41.5 million, up from $17.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $41.5 million in Q1 2026 and bottomed at $1.1 million in Q1 2025.
- The 5-year median for Cash & Equivalents is $7.6 million (2022), against an average of $8.8 million.
- The widest annual swing landed in 2022, when Cash & Equivalents surged 149361.29%; it then slumped 87.23% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $6.5 million in 2022, then soared by 67.96% to $10.9 million in 2023, then sank by 67.45% to $3.6 million in 2024, then surged by 378.53% to $17.0 million in 2025, then surged by 143.84% to $41.5 million in 2026.
- The last three Cash & Equivalents figures came in at $41.5 million (Q1 2026), $17.0 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 41.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.53 Mn |
| Dec 31, 2025 | 17.03 Mn |
| Sep 30, 2025 | 7.61 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 4.77 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 10.94 Mn |
| Sep 30, 2023 | 2.69 Mn |
| Jun 30, 2023 | 3.90 Mn |
| Mar 31, 2023 | 3.57 Mn |
| Dec 31, 2022 | 6.51 Mn |
| Sep 30, 2022 | 7.60 Mn |
| Jun 30, 2022 | 9.48 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | 4,356.00 |
| Sep 30, 2021 | 45,095.00 |
| Jun 30, 2021 | 29,271.00 |
| Mar 31, 2021 | 22,507.00 |
| Dec 31, 2020 | 191,852.00 |